A Study to Evaluate Topically Applied SXR1096 Cream in Patients With Netherton Syndrome

PHASE1/PHASE2UnknownINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 7, 2021

Primary Completion Date

August 31, 2022

Study Completion Date

December 20, 2022

Conditions

Netherton Syndrome

Interventions

DRUG

SXR1096 cream

Skin cream to be applied twice a day to a predefined area of the skin

DRUG

Placebo cream

Skin cream to be applied twice a day to a predefined area of the skin

Trial Locations (1)

RECRUITING

Saint Louis Hospital, Paris